Objective Since the last epidemiologic review of neuromyelitis optica/neuromyelitis optica
spectrum disorder (NMO/NMOSD), 22 additional studies have been conducted. We …

Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple
sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies …

Objective To describe clinical and radiologic features associated with myelin
oligodendrocyte glycoprotein antibodies (MOG-Ab) in a large French nationwide adult …

Introduction Severe attacks of neuromyelitis optica spectrum disorder (NMO-SD) are
improved by plasma exchange (PLEX) given as an adjunctive therapy. Initial studies failed …

Importance Most patients with neuromyelitis optica (NMO) and many with NMO spectrum
disorder have autoantibodies against aquaporin-4 (AQP4-Abs), but recently, myelin …

Objective Neuromyelitis optica (NMO) and its spectrum disorders (NMOSD) are inflammatory
demyelinating diseases (IDDs) with a specific biomarker, aquaporin‐4–immunoglobulin G …

Objective To report the clinical, radiological, and immunological association of
demyelinating disorders with anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis …

The comparative clinical and demographic features of neuromyelitis optica (NMO) are not
well known. In this review we analyzed peer-reviewed publications for incidence and …

Myelin oligodendrocyte glycoprotein (MOG) is a protein exclusively expressed on the
surface of oligodendrocytes and myelin in the central nervous system. MOG has been …

Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have been found in
some cases diagnosed as seronegative neuromyelitis optica spectrum disorder (NMOSD) …